title: Pegylated interferon for the treatment of hepatitis C virus in haemodialysis patients.
authors.affiliation: Division of Nephrology, CHUV, Rue du Bugnon 17, 1011 Lausanne, Switzerland.
authors.forename: Daniel
authors.initials: D
authors.lastname: Teta
authors.forename: Brigitte Landtwing
authors.initials: BL
authors.lastname: Lüscher
authors.forename: Jean-Jacques
authors.initials: JJ
authors.lastname: Gonvers
authors.forename: Patrick
authors.initials: P
authors.lastname: Francioli
authors.forename: Olivier
authors.initials: O
authors.lastname: Phan
authors.forename: Michel
authors.initials: M
authors.lastname: Burnier
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use*; D006526:Hepatitis C / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011092:Polyethylene Glycols / Q000009:adverse effects / Q000627:therapeutic use*; D012367:RNA, Viral / Q000097:blood; D011994:Recombinant Proteins; D006435:Renal Dialysis / Q000009:adverse effects*
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D012367:RNA, Viral; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; C100416:peginterferon alfa-2a